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ABSTRACT  
Objective: The aim of the present study was to formulate a microemulsion for the oral delivery of Glipizide.  
Methods: Microemulsion systems composed of oleic acid, isopropyl myristate as oils; tween 80, span 20 and cremophor EL as surfactants; 
propylene glycol, isopropyl alcohol as cosurfactants were investigated as potential drug delivery vehicle for delivery for glipizide. Pseudo-ternary 
phase diagram of the investigated system at constant surfactant concentration and varying oil/water or oil/cosurfactant ratios was constructed at 
room temperature by titration method. This allowed studying structural inversion from oil-in-water to water-in–oil microemulsion. Furthermore, 
electrical conductivity, in vitro dissolution studies, pH, centrifugation, % transmittance, viscosity, particle size, polydispersity index, zeta potential, 
DSC and accelerated stability studies were conducted.  
Results: The results of electrical conductivity clearly indicated the structural inversion. Based on these values oil/water microemulsions were 
selected. The plain drug has shown only 40% of dissolution, while the drug from all the o/w microemulsions has shown>90% dissolution. Based on 
in vitro release studies f3, f12, f22 formulations were chosen. Particle size values of f3, f12, f22 formulations are 202.4 nm, 83.3 nm, 315.3 nm 
respectively. Viscosity results showed that the formulations follow the Newtonian flow. 
Conclusion: The 3 formulations f3, f12 and f22 were successful in increasing the dissolution of glipizide in GIT and capable of sustaining the release 
of the drug for 8 h. From the viscosity, particle size, polydispersity index values, f12 was considered as the optimized formulation. Further, 
centrifugation, zeta potential and accelerated stability studies also indicated that the formulations were stable. DSC studies revealed no drug-
excipient interaction in the optimized formulation. Owing to the above results microemulsion can be thus considered as a suitable oral delivery 
system for glipizide.  
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INTRODUCTION 
During the recent decades, various colloidal systems have been 
investigated as suitable pharmaceutical vehicles for oral delivery of 
the active substance. Microemulsions are thermodynamically stable 
isotropically clear systems in which two immiscible liquids (i.e., 
water and oil) are mixed to form a single phase with an appropriate 
surfactant or its mixture. Hoar and Schulman introduced the word 
microemulsion, which they defined as a transparent solution 
obtained by titrating a normal coarse emulsion with medium-chain 
alcohols [1]. The short to medium chain alcohols are generally 
considered as co-surfactants in the microemulsion system. The 
presence of surfactant and co-surfactant in the system makes the 
interfacial tension very low.  
A microemulsion is considered as a suitable candidate for the oral 
delivery of poorly water-soluble drugs. It has the ability to improve 
drug solubilization, protection against enzymatic hydrolysis and 
enhance the potential for absorption of hydrophilic, hydrophobic 
and amphiphilic substances in the gastrointestinal tract (GI), caused 
by surfactant-induced permeability changes [2-6]. After oral 
administration, it readily disperses in the stomach to a small droplet 
of the microemulsion, which promotes a wide distribution of the 
drug throughout the GI tract. Microemulsion comprises structures 
such as water in oil (w/o), oil in water (o/w) and bicontinuous 
systems. These help in the release of the drug. The microemulsion 
can also sustain the release the drug if the partitioning of the drug 
between water and oil phases strongly affects the drug release [7-9]. 
It can be formulated as an oil in water and water in oil 
microemulsion. Oil in water microemulsion is considered as a 
promising approach to improve the solubility and oral 
bioavailability of hydrophobic drugs such as cyclosporine [10] and 
also to sustain the release. Hydrophobic drugs will be solubilized in 
the dispersed phase and the thick layer of an emulsifying agent that 
surrounds the dispersed phase helps in sustaining the release of the 
drug. On the other hand, water in oil microemulsion is considered as 
an approach to improve the bioavailability and to sustain the release 
of hydrophilic drugs across the intestinal mucosa [11]. Therefore, it 
is important in our study to formulate oil in water microemulsion to 
improve the oral delivery of a hydrophobic drug, glipizide. 
Glipizide, a second generation sulfonylurea, is used for patients with 
non-insulin dependent diabetes mellitus who have failed diet and 
exercise therapy. It appears to be the most effective insulin 
secretagogue both in first phase insulin secretion and in sustained 
stimulatory response during long-term administration. It is a 
sparingly water-soluble drug with a solubility of 37.2 mg/l. The 
percentage release and the bioavailability of glipizide given orally 
are low [12]. The novelty in the work is to develop a novel oral 
formulation of poorly water soluble drug, glipizide, which was not 
reported earlier with the used ingredients. A vast in vitro study was 
also performed. So, in the present study, a microemulsion of 
glipizide was developed and evaluated in vitro to increase the 
percentage of drug release in GIT and also to sustain the release with 
a hope of improving the bioavailability and half-life of the drug in 
further studies. 
MATERIALS AND METHODS 
Glipizide was provided as a gift sample from Aurobindo laboratories 
Ltd, Hyderabad, India. Cremophor EL was obtained from Signet 
chemical corporation, Mumbai, India. Oleic acid, isopropyl myristate, 
isopropyl alcohol, propylene glycol, ethanol, tween 80, span 20, 
sodium chloride were obtained from SD fine chemicals Private 
Limited, Gujarat, India. Solvents and all the reagents were of 
analytical grade. 
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Construction of phase diagram  
Phase diagrams were used to construct different regions of 
microemulsion formation, from which a large number of potential 
microemulsions could be determined [13]. The pseudo-ternary 
phase diagram was constructed by titration of homogeneous liquid 
mixtures of oil, surfactant, and water with a cosurfactant at room 
temperature. Oil, glipizide, surfactant and water blend were 
prepared and cosurfactant was added drop by drop, under 
mechanical stirring. In this experiment, the contents of oil and water 
were varied in the ratio of 90:10 to 10:90. Transparent, single-phase, 
low viscous mixtures were designated as a microemulsion. After the 
cosurfactant titration, in order to establish the microemulsion 
regions, phase diagrams were constructed for the following 3 
systems. 
System I-Oleic acid: Tween 80: Propylene glycol.  
System II-Isopropyl myristate: (Tween80-Span20): Isopropyl 
alcohol. 
System III-Oleic acid: Cremophor EL: Isopropyl alcohol 
Preparation of glipizide microemulsion 
Microemulsions were prepared by cosurfactant titration method 
[14]. In this method about 2.5 mg of glipizide for 5 ml formulation 
was accurately weighed and taken in a beaker. It was dissolved in an 
appropriate amount of oil. To this required amount of surfactant and 
water were added. The preparation was then gently stirred with a 
mechanical stirrer until all the components were mixed properly. 
Cosurfactant was then added dropwise to this preparation until the 
solution was clear. The samples were then stirred for 15 min to 
allow equilibration.  
Characterization of microemulsion 
Conductivity measurements 
The electrical conductivity of the samples was measured using a 
Digital pH/conductivity meter (model DI-707, Digisun electronics, 
Hyderabad). Conductivity was measured by using 0.01N sodium 
chloride solution instead of using water. The measurements were 
performed in triplicate at 25 °C 
In vitro drug release studies 
Dialysis tube method was used for performing the dissolution 
process. In this method, a boiling tube was taken which was 
opened at both the ends [15]. To this tube, a cellophane 
membrane was attached at one end, which was previously 
soaked in 7.4 pH buffer for 24 h. 5 ml of microemulsion was 
taken from the other end of the tube. This setup was attached to 
the paddle of the dissolution apparatus. The dissolution medium 
consisted of 50 ml of freshly prepared phosphate buffer of pH 
7.4. The release study was performed at 37±0.5 o
pH determination  
C, with a 
rotation speed of 50 rpm. Samples of 3 ml were withdrawn at 1, 
2, 3 up to 8 h at regular one-hour intervals and replaced with 
fresh medium. Dissolution of placebo microemulsion was 
performed in the same manner and samples were utilized as 
blank for the respective drug loaded microemulsion. The 
samples were analyzed by UV-Visible spectrophotometer at 276 
nm. The release studies were performed in triplicate. 
The pH values of the samples were measured by a Digital pH meter 
(model DI-707, Digisun electronics, Hyderabad) at 37±1 o
Centrifugation 
C. 
In order to eliminate metastable systems, the selected drug-loaded 
microemulsions were centrifuged (Research Centrifuge, R-24, Remi 
Instruments Limited, Mumbai) at 4000 rpm for 4 h. 
Percent transmittance 
The percent transmittance of the system was measured using UV-
Visible double beam spectrophotometer (model-2201, Systronics) at 
560 nm using distilled water as a blank. 
Rheological studies 
The viscosity of the samples was measured using Brookfield 
Viscometer LVDV-II+P (Brookfield Engineering Laboratories, Inc. 
Middleboro, United states) fitted with an S-32 spindle. A Sample 
volume of 15 ml was used. All the microemulsions studied were 
subjected to shear stress of 0-20 Pa at different rpm (3, 6, 12, 30 and 
60) and the rheological behavior of the disperse systems were 
examined by constructing rheograms of shear stress vs. shear rate. 
Particle size, Polydispersity index and Zeta potential 
measurement 
Measurements were made on a Zetasizer Nano ZS instrument at 25 
°C at a wavelength of 633 nm and incorporate non-invasive 
backscatter optics (NIBS). At a detection angle of 173 °C 
measurements were made.  
Differential scanning calorimetry measurements (DSC) 
DSC measurements were performed with DSC TA Q100 instrument 
equipped with a refrigerated cooling system. Nitrogen with a flow 
rate of 50 ml/min was used as purge gas. Approximately 4 to 13 mg 
of sample was weighed precisely into hermetic aluminum pans. An 
empty hermetically sealed pan was used as a reference. Samples 
were cooled from 25 oC to −50 oC at a cooling rate of 5 oC/min, held 
for 3 min at −50 oC and then heated to 25 °C at a heating rate of 10 
o
Stability studies of optimized formulation 
C/min. All measurements were performed in triplicate. 
Stability studies were carried out for optimized formulation for 6 mo 
at 37±2 °C and 04±2 °C according to ICH guideline in a controlled 
chamber. The sample was analyzed periodically for physical 
appearance, rheological properties, pH and percentage release by 
UV-Visible spectrophotometer at 276 nm. 
RESULTS AND DISCUSSION 
Oleic acid, isopropyl myristate were lipophilic permeation 
enhancers and can be used to improve the membrane permeability 
of microemulsion [16, 17]. Tween 80, span 20, cremophor EL were 
nonionic surfactants and categorized as generally recognized as safe 
(GRAS) excipients, which were widely used in pharmaceutical 
preparations [18-20]. Surfactants were used in microemulsion 
preparation such that their hydrophilic lipophilic balance value is 
greater than 10. Cosurfactants propylene glycol, isopropyl alcohol 
were used in the concentration which was safe for oral use.  
Pseudo-ternary phase diagram 
A pseudo ternary phase diagram was constructed to determine the 
composition of the aqueous phase, oil phase, and surfactant: a co-
surfactant phase that will yield a microemulsion. Among the various 
phases formed by these four components a field with clear and 
transparent liquid microemulsions was identified. A pseudo ternary 
phase diagram of microemulsions prepared with system I was 
represented in fig. 1(a). At low concentrations of water, clear 
microemulsions were obtained. But at concentrations>18%, gel-like 
preparation was formed. Replacement of water with 0.01N sodium 
chloride solution produced the same microemulsions as that 
obtained with water. This was not surprising, as the various 
components of microemulsion were non-ionic and thus unaffected 
by the ionic strength of the dispersed aqueous phase. It was clear 
from the pseudo-ternary phase diagram that, microemulsions in this 
system was formed with less than 18% of water, 2.84-32.73% of 
oleic acid, 45% of tween 80 and 17% of propylene glycol.  
The pseudo-ternary phase diagram of system II was shown in fig. 
1(b). In this system the ratio of tween 80:span20 was 1:1. This 
combination of surfactant produced a broader range of 
microemulsions as compared with the other microemulsion 
systems. It appears that stable microemulsions were formed with 3-
47% of water, 3-42% of isopropyl myristate, 27% of tween80: 
span20 (1:1) and 25% of isopropyl alcohol. A representative phase 
diagram of system III was shown in fig. 1(c). Water concentration of 
up to 32% was used. Above this concentration, gel-like preparation 
was observed. Stable microemulsions were formed with<32% of 
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water, 2-28% of isopropyl myristate, 45% of cremophor EL: tween 








Fig. 1: Pseudo-ternary phase diagrams of a) system I b) system 
II c) system III 
 
Characterization of microemulsion 
Conductivity studies 
Conductivity studies were performed by including sodium chloride 
solution in microemulsion instead of water. The electrical 
conductivity (σ) of the system I, as a function of percentage water 
content (Φw), was presented in fig. 2 (a). At concentrations of 
water<5% the conductivity of system I was 126mv. During water 
titration of>5%, the conductivity was suddenly increased to 176 mv. 
From Φw 6.66-17.75% (w/w), the conductivity of the system was 
not significantly affected by the further addition of water. After 
17.75% there was no addition of water, a further addition of water 
lead to the formation of a gel. The increase in water incorporation 
was because of the presence of propylene glycol. When the volume 
of water increases, the electrical conductivity slightly increases until 
the critical Φw was reached where a sudden increase in conductivity 
was observed. This phenomenon was called as percolation, and the 
percentage of water at which it occurs is known as percolation 
threshold (Φp) [21]. The percolation threshold was observed at 
13.2% water, where a network of conductive channels exists, which 
corresponds to the formation of water cylinders or channels in an oil 
phase due to the attractive interactions between the spherical 
microdroplets of the water phase in the w/o microemulsion. The 
Percolation threshold of up to 20% was observed in piroxicam 
microemulsion [22]. For the Φw>16.64% (w/w) the conductivity 
data can be explained by the dilution of microemulsion with the 
added water, which decreased the concentration of the dispersed oil 
droplets and increased conductivity. Thus, this σ–Φw curve 
illustrates the occurrence of the three structural regions: W/O 
(Φw<13.2% (w/w)), nonspherical W/O–bicontinuous–non-
spherical O/W (13.2% (w/w)<Φw<16.64% (w/w)), and O/W 








Fig. 2: Conductivity vs Фw profile of a) system I b) system II  
c) system III 
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The electrical conductivity of system II was presented in fig. 2 (b). At 
low fractions of water, i.e.<18%, the conductivity slowly increased 
from 72mv to77mv. After Φw ~18% there was an increase in 
conductivity. From 18 %<Φw<32% there was no significant increase 
in conductivity with the addition of water. At Φw>32% there was 
again a raise in the curve. Further addition of water caused no 
significant increase in the conductivity of water. Thus, this σ–Φw 
curve illustrates the occurrence of the three structural regions: W/O 
(Φw<18% (w/w)), nonspherical W/O–bicontinuous–non-spherical 
O/W (18% (w/w)<Φw<32% (w/w)), and O/W (Φw>32% (w/w)). 
The electrical conductivity of system III was illustrated in fig.2 (C). 
At low levels of Φw<19% (w/w), there was a slow increase in the 
conductivity of water. After Φw>19%, there was a steep increase in 
the conductivity of the formulation. After that, there was a slow 
increase in the conductivity of water until Φw ~ 31.45%. Then a 
sudden increase in the conductivity was observed with the added 
water. Thus, this σ–Φw curve illustrates the occurrence of the three 
structural regions: W/O (Φw<19% (w/w)), nonspherical W/O–
bicontinuous–non-spherical O/W (19% (w/w)<Φw<31.45% 
(w/w)), and O/W (Φw>31.45% (w/w). The observed conductivity 
curves of the 3 investigated systems as a function of water content 
enumerates the use of conductivity to measure the structural 
changes in microemulsions [23]. 
From the conductivity studies, O/W microemulsions were selected 
for carrying out in vitro dissolution studies [table 1].  
In vitro dissolution studies 
The dissolution studies of these microemulsions were compared 
with the dissolution profile of the plain drug. The release 
percentages at regular intervals were calculated and represented 
below in fig. 3. 
 
Table 1: O/W microemulsions of glipizide selected from conductivity studies 
















F1 2.84  _ 44.81  _  _  _ 34.37 17.75 
F2 5.71  _ 45.02  _  _  _ 32.22 17.03 
F3 11.53  _ 45.45  _  _  _ 26.79 16.26 
F10  _ 2.98 14.6 14.6  _ 22.04  _ 46.36 
F11  _ 9.09 14.77 14.77  _ 22.27  _ 39.07 
F12  _ 12.18 14.85 14.85  _ 22.39  _ 35.7 
F20 2.90  _  _  _ 43.6 21.95  _ 31.53 
F21 5.99  _  _  _ 43.84 22.06  _ 28.10 
F22 9.03  _  _  _ 44.06 22.17  _ 24.71 
*IPA-Isopropyl alcohol, *PG-Propylene glycol, *IPM-Isopropyl myristate, *CEL-Cremophor EL 
 
 
Fig. 3: In vitro release profile of o/w microemulsions data 
represents mean±SD (n=6) 
 
Dissolution studies of pure glipizide have shown only 40% release 
owing to its poor dissolution and solubility in water. Formulation f1 
have shown 93% release within 2 h, but not able to sustain the 
release. The fast release may be because of more amount of 
propylene glycol in the formulation which enhances the 
permeability of drug and also the presence of less oil content. This 
formulation can be suggested as immediate release formulation of 
glipizide. Formulations f2, f10, f11, f20, f21 showed good percentage 
release but are not capable of sustaining the release. However the 
formulations f3, f12, f22 showed>95% release and also sustained the 
release for 8 h. This may be because of the more internal oil phase and 
more solubilization of the drug in the oil phase. So, it takes time for the 
drug to diffuse through oil phase, surfactants, enter into the water phase 
and then reach the surrounding buffer. Hence, the formulations f3, f12, 
f22 were chosen taken for further studies. S. N. Deepak has shown 
similar dissolution profile for guaifenesin and phenylephrine 
microemulsion (100% drug release in 6 h), where oleic acid, tween 80, 
water and 2-propanol were used as formulation ingredients. 
The cumulative percentage release of each optimized formulation at 
different time periods was fitted in various kinetic models [table 2]. 
The r2
 
 values>0.976 reveals that the drug follows zero order release 
profile. The value of n>0.8 indicates super case II transport of 
glipizide from microemulsion. This shows that the rate-limiting step 
in the release of glipizide was dissolution controlled release and not 
diffusion controlled release. 
Table 2: Release kinetics of microemulsions selected 
Formulation code Parameters Zero order First order Hixson crowell (Q1/3 Koresmeyer peppas (n) -Qt) 
F3 slope 0.125 -0.0001 3.736 0.825 
r 0.9760 2 0.961 0.970 0.977 
F12 slope 0.141 -0.001 4.122 1.031 
r 0.979 2 0.923 0.930 0.892 
F22 slope 0.137 -0.001 4.003 0.922 
r 0.994 2 0.865 0.936 0.992 
 
pH studies were performed for the three formulations and found 
that the formulations have a pH near to neutrality. This indicates 
that they are not too acidic nor too basic, thus safe to take it orally. 
Centrifugation studies were done at 4000 rpm for 4 h and no phase 
separation was observed in all the optimized formulations which 
show that the samples were not metastable forms, which undergo 
phase separation easily, but were stable. Percentage transmittance 
studies were performed at 560 nm by using UV-Vis 
spectrophotometer. The results have shown>99.90% transmittance, 
which indicates that the microemulsions were transparent which is 
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considered as the primary property of a microemulsion [table 3]. 
The rheological studies of chosen formulations were investigated at 
4 different shear rates at 303 °K which was shown in fig. 4. It was 
observed that viscosity was constant with an increase in the shear 
rate for all the compositions. This indicates that the sample follows 
the Newtonian flow. The results of the rheological study also have 
shown low viscosity values. So, it is considered that the other 
characteristic property of microemulsion, i.e., the low viscosity was 
met. Hence, Newtonian flow and lower viscosity values help in easy 
packaging, handling of the microemulsion and also helps to increase 
patient compliance upon oral administration. Out of the three 
formulations, f12 has viscosity very much lower than the other two 
formulations. Particle size analysis indicates that the size and 
polydispersity index (PDI) of f12 is much lower than formulations f3 
and f22 [fig. 5]. Lower the particle size; greater is the permeation of 
microemulsions through the gastrointestinal tract and greater will 
be the bioavailability. PDI values of f12 indicate that droplet size in 
the formulation was uniform. The results of zeta potential showed 
that all the optimized formulations have good physical stability. The 
values confirm a net negative charge on the surface of the globule. 
From the above results of viscosity, particle size, PDI and zeta 
potential f12 formulation was optimized as a final microemulsion. 
Further differential scanning calorimetric studies (DSC) were 
performed to determine its stability and drug entrapment. 
 
Table 3: Evaluation studies of selected o/w formulations 
Formulations pH %Transmittance Viscosity(cps) Particle size(nm) PDI Zeta potential 
    Peak1 Peak2 Peak3   
F3 6.87±0.05 99.93±0.01 210±2.3 10±0.2 25±0.31 315.3±2.9 0.608±0.04 -27.2±0.2 
F12 6.72±0.15 99.99±0.01 30±0.67 10±0.09 83.3±0.45 - 0.120±0.01 -29.8±0.1 
F22 6.98±0.04 99.98±0.2 150±0.45 30±0.11 183±1.6 - 0.452±0.02 -25.7±0.4 
Data represents mean±SD (n=3). 
 
  
Fig. 4: Effect of shear stress on different rates of shear. Data 





Fig. 5: Particle size distribution of selected formulations 
 
Differential scanning calorimetric study 
Formulation f12 showed endotherms at 124.4 oc and 247 oC. 
Formulation f12 placebo showed endotherms at 128.6 and 254.2 oC 
[fig. 6]. Isopropyl myristate (IPM) oil showed endotherm at 212 oC. 
The endotherm of f10 at 247 oc and endotherm of placebo at 254.2 
o
 
C was due to the presence of IPM in the formulations. In f12, no 
peak for the drug was observed indicating that the drug was 
completely solubilized in the formulation.  
 
Fig. 6: DSC thermogram of glipizide, isopropyl myristate, f12 
and f12 placebo 
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Further, stability studies were carried out for optimized formulation 
as per ICH guidelines at 37±2 °C, 4±2 °C in a controlled chamber. In 
periodic time intervals samples were withdrawn and retested for 
physical appearance, viscosity, pH and in vitro release for 6 mo. The 
physical appearance of the preparation was good without any phase 
separation or turbidity. The average pH of 6.8, viscosity of 40 cps 
and no considerable change in the percentage release, i.e., 95% was 
observed for 6 mo.  
CONCLUSION 
Pseudo-ternary phase diagram for the three microemulsion systems 
was delineated. Conductivity studies depicted the structural changes 
from w/o to o/w via bicontinuous phase. Particle size, viscosity, % 
transmittance, zeta potential studies were performed on selected 
formulations. From the three selected microemulsions, f12 was 
optimized. DSC, stability studies indicated that the formulation was 
stable. It was concluded the microemulsion f12 can be considered as 
a useful dosage form for oral intake of glipizide. Further in vivo tests 
have to be carried out to know the pharmacokinetic and 
pharmacodynamics parameters of the optimized formulation. 
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